The Atherogenic Index of Plasma is Associated With Cerebral Small Vessel Disease: A Cross-Sectional Study
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Recently, the lipid profile of atherogenic dyslipidemia has become important in cerebrovascular diseases. Atherogenic index of plasma (AIP), an index that reflects this lipid profile as a single number, has been proposed, but there are still few related studies in cerebrovascular disease. In this study, we evaluated the relationship between AIP and cerebral small vessel disease (cSVD) in health check-up participants. Methods: We assessed consecutive health check-ups participants between 2006 and 2013. cSVD was measured including the following three subtypes: white matter hyperintensity (WMH), lacuens, and cerebral microbleeds (CMBs). WMH quantitatively measured the volume, and lacunes and CMBs qualitatively evaluated the presence. AIP was calculated according to the following formula based on blood test results: AIP=log [triglyceride (mg/dL)/high-density lipoprotein cholesterol (mg/dL)]. Results: A total of 3,170 participants were evaluated (mean age: 56.5 years, male sex: 53.8%). In multivariable linear regression analysis, AIP (β=0.129, 95% confidence interval [CI]=0.003-0.255) was associated with WMH. Age, hypertension, diabetes, lipid-lowering agents, and intracranial atherosclerosis were also associated with WMH volume. In multivariable logistic regression analysis, AIP (adjusted odds ratio=1.72 1.79, 95% CI=1.03-2.90) showed close association with lacunes. Age and intracranial atherosclerosis were also related to lacunes. CMBs did not show a statistically significant association with AIP. Conclusion: High AIP was associated with cSVD in health check-up participants. Since this close relationship was only seen in WMH and lacunes, these subtypes may have arisen from a more atherosclerosis-related pathology.
Abstract
Objective: Recently, the lipid profile of atherogenic dyslipidemia has become important in cerebrovascular diseases. Atherogenic index of plasma (AIP), an index that reflects this lipid profile as a single number, has been proposed, but there are still few related studies in cerebrovascular disease. In this study, we evaluated the relationship between AIP and cerebral small vessel disease (cSVD) in health check-up participants. Methods: We assessed consecutive health check-ups participants between 2006 and 2013. cSVD was measured including the following three subtypes: white matter hyperintensity (WMH), lacuens, and cerebral microbleeds (CMBs). WMH quantitatively measured the volume, and lacunes and CMBs qualitatively evaluated the presence. AIP was calculated according to the following formula based on blood test results: AIP=log [triglyceride (mg/dL)/high-density lipoprotein cholesterol (mg/dL)]. Results: A total of 3,170 participants were evaluated (mean age: 56.5 years, male sex: 53.8%). In multivariable linear regression analysis, AIP (β=0.129, 95% confidence interval [CI]=0.003-0.255) was associated with WMH. Age, hypertension, diabetes, lipid-lowering agents, and intracranial atherosclerosis were also associated with WMH volume. In multivariable logistic regression analysis, AIP (adjusted odds ratio=1.72 1.79, 95% CI=1.03-2.90) showed close association with lacunes. Age and intracranial atherosclerosis were also related to lacunes. CMBs did not show a statistically significant association with AIP. Conclusion: High AIP was associated with cSVD in health check-up participants. Since this close relationship was only seen in WMH and lacunes, these subtypes may have arisen from a more atherosclerosis-related pathology.
참고문헌 (31)
- Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
- Shi Y, "Update on cerebral small vessel disease : a dynamic whole-brain disease", Stroke Vasc Neurol, 1, pp.83~92 (2016)
- Nam KW, "High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population : a cross-sectional study", Cardiovasc Diabetol, 19, pp.53~ (2020)
- Eun-Jae Lee, "Silent New Brain Lesions: Innocent Bystander or Guilty Party?", 대한뇌졸중영문학회지, 18(1), pp.38~49 (2016), 대한뇌졸중학회
- Appleton JP, "Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke", Neurology, 94, pp.e439~e452 (2020)
- Alvar A, "The role of white matter in the neural control of swallowing : a systematic review", Front Hum Neurosci, 15, pp.628424~ (2021)
- Zhang L, "Total magnetic resonance imaging of cerebral small vessel disease burden predicts dysphagia in patients with a single recent small subcortical infarct", BMC Neurol, 22, pp.1~12 (2022)
- Zhou X, "Altered brain function in cerebral small vessel disease patients with gait disorders : a resting-state functional MRI study", Front Aging Neurosci, 12, pp.234~ (2020)
- Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
- Clarkson TB, "Mechanisms of atherogenesis", Circulation, 76, pp.I20~I28 (1987)
- Grundy SM, "2018 AHA", ACC, AAPA, pp.ABC, ACPM[DOI]
- 조소미, "Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data", 지질·동맥경화학회지, 10(2), pp.202~209 (2021), 한국지질동맥경화학회[DOI]
- Duran EK, "Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease", J Am Coll Cardiol, 75, pp.2122~2135 (2020)
- Grundy SM, "Small LDL, atherogenic dyslipidemia, and the metabolic syndrome", Circulation, 95, pp.1~4 (1997)
- Musunuru K, "Atherogenic dyslipidemia : cardiovascular risk and dietary intervention", Lipids, 45, pp.907~914 (2010)
- Dobiásová M, "The plasma parameter log(TG", HDL-C)as an atherogenic index : correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma(FER(HDL)), 2001, pp.34, 583~588
- Won KB, "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors", Atherosclerosis, 324, pp.46~51 (2021)
- Ni W, "Gender-and lesion number-dependent difference in"atherogenic index of plasma"in Chinese people with coronary heart disease", Sci Rep, 7, pp.13207~ (2017)
- Zheng Y, "Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention : a prospective study of the long-term outcomes in China", Cardiovasc Diabetol, 21, pp.29~ (2022)
- Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)
- Barnett HJ, "Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis", N Engl J Med, 325, pp.445~453 (1991)
- Frohlich J, "Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography", Clin Chem, 49, pp.1873~1880 (2003)
- Yoshida H, "Mechanisms of LDL oxidation", Clin Chim Acta, 411, pp.1875~1882 (2010)
- Labreuche J, "Plasma triglyceride levels and risk of stroke and carotid atherosclerosis : a systematic review of the epidemiological studies", Atherosclerosis, 203, pp.331~345 (2009)
- Assmann G, "HDL cholesterol and protective factors in atherosclerosis", Circulation, 109(Suppl 1), pp.III8~III14 (2004)
- Wardlaw JM, "Mechanisms of sporadic cerebral small vessel disease : insights from neuroimaging", Lancet Neurol, 12, pp.483~497 (2013)
- Ren X, "Association between triglyceride to HDL-C ratio(TG", HDL-C)and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus, 2016, pp.11, e0154345~
- Pantoja-Torres B, "High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults", Diabetes Metab Syndr, 13, pp.382~388 (2019)
- Muniyappa R, "Role of insulin resistance in endothelial dysfunction", Rev Endocr Metab Disord, 14, pp.5~12 (2013)
- Kim JA, "Reciprocal relationships between insulin resistance and endothelial dysfunction : molecular and pathophysiological mechanisms", Circulation, 113, pp.1888~1904 (2006)
- Ohwaki K, "Hypercholesterolemia is associated with a lower risk of cerebral ischemic small vessel disease detected on brain checkups", Clin Neurol Neurosurg, 115, pp.669~672 (2013)